EpilepsyGTx and Viralgen have entered a collaboration to support manufacturing of EPY201, an investigational adeno-associated virus (AAV)-based gene therapy being developed for patients with focal ...
Dravet syndrome begins deceptively. Infants who appear completely normal in the first year of life develop their first ...
SHIELD randomizes ~150 adults (18–65 years) to placebo-controlled evaluation of valacyclovir/celecoxib with an added 25-day ...
The FDA has approved tavapadon (AbbVie), a once-daily oral selective dopamine D1/D5 receptor partial agonist, for adults with ...
NeurologyLive Brain Games is a weekly quiz series that goes live every Sunday morning, featuring questions on a variety of ...
The FDA extended its review of relutrigine for SCN2A- and SCN8A-related epilepsies by three months, pushing the PDUFA date to ...
The professor of neurology at the University of Cincinnati discussed how clinical awareness of social determinants and expanded telehealth have begun to move the needle for stroke care. [WATCH TIME: 7 ...
Beginning with FDA news, the administration Xenon Pharmaceuticals has submitted a new drug application (NDA) to the FDA for ...
A retrospective cohort study found DTI-ALPS, a glymphatic function marker, did not independently predict survival in ...
Exploring the Link Between Football Players and ALS: Brian Lin, PhD In a recent Q&A interview, Brian Lin, PhD, research ...
Neurology moves fast, and the assumptions that shape how we practice do not always keep up. Gray Areas is a NeurologyLive ...
In recognition of International Ataxia Awareness Day, observed annually on NeurologyLive® reviews 6 investigational agents ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results